Public information

Published on 23 April 2025

Genetic testing helps us to better understand certain diseases, to diagnose them earlier and more accurately, and, in some cases, to propose appropriate treatment. They can be carried out at various stages of life, notably before or during pregnancy. To answer any questions these tests may raise, the Agence de la biomédecine provides clear, reliable and regularly updated information.

Providing information on medical genetics

Scientific advances in this field now make it possible to better identify predispositions to certain diseases, establish more precise diagnoses and improve patient care. These advances open up new prospects, but also raise questions about access to tests, their interpretation and their consequences for patients and their families. In this context, information plays an essential role. The Agence de la biomédecine develops educational materials for all audiences, based on scientific and regulatory monitoring, as well as on the expertise of professionals.

Understanding genetic testing and its implications

The Agence de la biomédecine provides the public with reliable, accessible information on medical genetics and genetic testing. This content enables everyone - patients or patients' relatives, future parents or simple users - to gain a better understanding of possible therapeutic indications, how examinations are carried out and the issues they raise. This information focuses in particular on prenatal diagnosis (PND) and pre-implantation diagnosis (PGD), which can involve sensitive situations and require informed support. It is designed in close collaboration with healthcare professionals and associations, to ensure that the information is relevant and easily understood by those concerned.

Share